Selected research
Industry Growth & Trends
Global Custom Synthesis and Radiolabeling Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Custom Synthesis and Radiolabeling market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Custom Synthesis and Radiolabeling is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Custom Synthesis and Radiolabeling is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Custom Synthesis and Radiolabeling is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Custom Synthesis and Radiolabeling market include Charles River, Eurofins Scientific, PerkinElmer, Sekisui Medical, Eckert & Ziegler, Labcorp, XenoTech (BioIVT), Quotient Sciences and Gifford Bioscience, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Custom Synthesis and Radiolabeling market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Custom Synthesis and Radiolabeling market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Custom Synthesis and Radiolabeling market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Custom Synthesis and Radiolabeling.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Custom Synthesis and Radiolabeling market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Custom Synthesis and Radiolabeling Market by Company
Charles River
Eurofins Scientific
PerkinElmer
Sekisui Medical
Eckert & Ziegler
Labcorp
XenoTech (BioIVT)
Quotient Sciences
Gifford Bioscience
ITM Radiopharma
Almac Group
Accelera
Novandi Chemistry
AptoChem
HMR
AM Chemicals
PolyPeptide Group
NovoPro Bioscience
Institute of Isotopes
Nuvisan
Revvity
Necsa
Fluorizon
Edinburgh Pharmaceutical Processes
Chelatec
Pharmaron
Medicilon
JOINN Laboratories
Frontage
Abace Biotechnology
Beijing Atom High-Tech
Wuxi Beita Pharmatech
Beijing North Institute of Biotechnology
Custom Synthesis and Radiolabeling Segment by Type
C-14
H-3
I-125
Others
Custom Synthesis and Radiolabeling Segment by Application
Drug Discovery
Medical
Others
Custom Synthesis and Radiolabeling Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom Synthesis and Radiolabeling market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Custom Synthesis and Radiolabeling and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom Synthesis and Radiolabeling.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Custom Synthesis and Radiolabeling companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- C-14
- H-3
- I-125
- Others
Applications
- Drug Discovery
- Medical
- Others
Companies covered
- Charles River
- Eurofins Scientific
- PerkinElmer
- Sekisui Medical
- Eckert & Ziegler
- Labcorp
- XenoTech (BioIVT)
- Quotient Sciences
- Gifford Bioscience
- ITM Radiopharma
- Almac Group
- Accelera
- Novandi Chemistry
- AptoChem
- HMR
- AM Chemicals
- PolyPeptide Group
- NovoPro Bioscience
- Institute of Isotopes
- Nuvisan
- Revvity
- Necsa
- Fluorizon
- Edinburgh Pharmaceutical Processes
- Chelatec
- Pharmaron
- Medicilon
- JOINN Laboratories
- Frontage
- Abace Biotechnology
- Beijing Atom High-Tech
- Wuxi Beita Pharmatech
- Beijing North Institute of Biotechnology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Custom Synthesis and Radiolabeling Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Custom Synthesis and Radiolabeling Market Size by Region (2021-2032)
- 1.4.1 Global Custom Synthesis and Radiolabeling Market Size by Region (2021-2026)
- 1.4.2 Global Custom Synthesis and Radiolabeling Market Size by Region (2027-2032)
- 1.5 Key Regions Custom Synthesis and Radiolabeling Market Size (2021-2032)
- 1.5.1 North America Custom Synthesis and Radiolabeling Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Custom Synthesis and Radiolabeling Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Custom Synthesis and Radiolabeling Market Size Growth Rate (2021-2032)
- 1.5.4 South America Custom Synthesis and Radiolabeling Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Custom Synthesis and Radiolabeling Market Size Growth Rate (2021-2032)
2 Custom Synthesis and Radiolabeling Market by Type
- 2.1 Type Introduction
- 2.1.1 C-14
- 2.1.2 H-3
- 2.1.3 I-125
- 2.1.4 Others
- 2.2 Global Custom Synthesis and Radiolabeling Market Size by Type
- 2.2.1 Global Custom Synthesis and Radiolabeling Market Size Overview by Type (2021-2032)
- 2.2.2 Global Custom Synthesis and Radiolabeling Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Custom Synthesis and Radiolabeling Market Size Forecasted by Type (2027-2032)
- 2.3 Global Custom Synthesis and Radiolabeling Market Size by Regions
- 2.3.1 North America Custom Synthesis and Radiolabeling Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Custom Synthesis and Radiolabeling Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Custom Synthesis and Radiolabeling Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Custom Synthesis and Radiolabeling Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Custom Synthesis and Radiolabeling Market Size Breakdown by Type (2021-2026)
3 Custom Synthesis and Radiolabeling Market by Application
- 3.1 Type Introduction
- 3.1.1 Drug Discovery
- 3.1.2 Medical
- 3.1.3 Others
- 3.2 Global Custom Synthesis and Radiolabeling Market Size by Application
- 3.2.1 Global Custom Synthesis and Radiolabeling Market Size Overview by Application (2021-2032)
- 3.2.2 Global Custom Synthesis and Radiolabeling Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Custom Synthesis and Radiolabeling Market Size Forecasted by Application (2027-2032)
- 3.3 Global Custom Synthesis and Radiolabeling Market Size by Regions
- 3.3.1 North America Custom Synthesis and Radiolabeling Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Custom Synthesis and Radiolabeling Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Custom Synthesis and Radiolabeling Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Custom Synthesis and Radiolabeling Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Custom Synthesis and Radiolabeling Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Custom Synthesis and Radiolabeling Industry Trends
- 4.2 Custom Synthesis and Radiolabeling Industry Drivers
- 4.3 Custom Synthesis and Radiolabeling Industry Opportunities and Challenges
- 4.4 Custom Synthesis and Radiolabeling Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Custom Synthesis and Radiolabeling Revenue (2021-2026)
- 5.2 Global Custom Synthesis and Radiolabeling Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Custom Synthesis and Radiolabeling Key Company Headquarters & Area Served
- 5.4 Global Custom Synthesis and Radiolabeling Company, Product Type & Application
- 5.5 Global Custom Synthesis and Radiolabeling Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Custom Synthesis and Radiolabeling Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Custom Synthesis and Radiolabeling Players Market Share by Revenue in 2025
- 5.6.3 2025 Custom Synthesis and Radiolabeling Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Charles River
- 6.1.1 Charles River Company Information
- 6.1.2 Charles River Business Overview
- 6.1.3 Charles River Custom Synthesis and Radiolabeling Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Charles River Custom Synthesis and Radiolabeling Product Portfolio
- 6.1.5 Charles River Recent Developments
- 6.2 Eurofins Scientific
- 6.2.1 Eurofins Scientific Company Information
- 6.2.2 Eurofins Scientific Business Overview
- 6.2.3 Eurofins Scientific Custom Synthesis and Radiolabeling Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Eurofins Scientific Custom Synthesis and Radiolabeling Product Portfolio
- 6.2.5 Eurofins Scientific Recent Developments
- 6.3 PerkinElmer
- 6.3.1 PerkinElmer Company Information
- 6.3.2 PerkinElmer Business Overview
- 6.3.3 PerkinElmer Custom Synthesis and Radiolabeling Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 PerkinElmer Custom Synthesis and Radiolabeling Product Portfolio
- 6.3.5 PerkinElmer Recent Developments
- 6.4 Sekisui Medical
- 6.4.1 Sekisui Medical Company Information
- 6.4.2 Sekisui Medical Business Overview
- 6.4.3 Sekisui Medical Custom Synthesis and Radiolabeling Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Sekisui Medical Custom Synthesis and Radiolabeling Product Portfolio
- 6.4.5 Sekisui Medical Recent Developments
- 6.5 Eckert & Ziegler
- 6.5.1 Eckert & Ziegler Company Information
- 6.5.2 Eckert & Ziegler Business Overview
- 6.5.3 Eckert & Ziegler Custom Synthesis and Radiolabeling Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Eckert & Ziegler Custom Synthesis and Radiolabeling Product Portfolio
- 6.5.5 Eckert & Ziegler Recent Developments
- 6.6 Labcorp
- 6.6.1 Labcorp Company Information
- 6.6.2 Labcorp Business Overview
- 6.6.3 Labcorp Custom Synthesis and Radiolabeling Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Labcorp Custom Synthesis and Radiolabeling Product Portfolio
- 6.6.5 Labcorp Recent Developments
- 6.7 XenoTech (BioIVT)
- 6.7.1 XenoTech (BioIVT) Company Information
- 6.7.2 XenoTech (BioIVT) Business Overview
- 6.7.3 XenoTech (BioIVT) Custom Synthesis and Radiolabeling Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 XenoTech (BioIVT) Custom Synthesis and Radiolabeling Product Portfolio
- 6.7.5 XenoTech (BioIVT) Recent Developments
- 6.8 Quotient Sciences
- 6.8.1 Quotient Sciences Company Information
- 6.8.2 Quotient Sciences Business Overview
- 6.8.3 Quotient Sciences Custom Synthesis and Radiolabeling Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Quotient Sciences Custom Synthesis and Radiolabeling Product Portfolio
- 6.8.5 Quotient Sciences Recent Developments
- 6.9 Gifford Bioscience
- 6.9.1 Gifford Bioscience Company Information
- 6.9.2 Gifford Bioscience Business Overview
- 6.9.3 Gifford Bioscience Custom Synthesis and Radiolabeling Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Gifford Bioscience Custom Synthesis and Radiolabeling Product Portfolio
- 6.9.5 Gifford Bioscience Recent Developments
- 6.10 ITM Radiopharma
- 6.10.1 ITM Radiopharma Company Information
- 6.10.2 ITM Radiopharma Business Overview
- 6.10.3 ITM Radiopharma Custom Synthesis and Radiolabeling Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 ITM Radiopharma Custom Synthesis and Radiolabeling Product Portfolio
- 6.10.5 ITM Radiopharma Recent Developments
- 6.11 Almac Group
- 6.11.1 Almac Group Company Information
- 6.11.2 Almac Group Business Overview
- 6.11.3 Almac Group Custom Synthesis and Radiolabeling Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Almac Group Custom Synthesis and Radiolabeling Product Portfolio
- 6.11.5 Almac Group Recent Developments
- 6.12 Accelera
- 6.12.1 Accelera Company Information
- 6.12.2 Accelera Business Overview
- 6.12.3 Accelera Custom Synthesis and Radiolabeling Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Accelera Custom Synthesis and Radiolabeling Product Portfolio
- 6.12.5 Accelera Recent Developments
- 6.13 Novandi Chemistry
- 6.13.1 Novandi Chemistry Company Information
- 6.13.2 Novandi Chemistry Business Overview
- 6.13.3 Novandi Chemistry Custom Synthesis and Radiolabeling Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Novandi Chemistry Custom Synthesis and Radiolabeling Product Portfolio
- 6.13.5 Novandi Chemistry Recent Developments
- 6.14 AptoChem
- 6.14.1 AptoChem Company Information
- 6.14.2 AptoChem Business Overview
- 6.14.3 AptoChem Custom Synthesis and Radiolabeling Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 AptoChem Custom Synthesis and Radiolabeling Product Portfolio
- 6.14.5 AptoChem Recent Developments
- 6.15 HMR
- 6.15.1 HMR Company Information
- 6.15.2 HMR Business Overview
- 6.15.3 HMR Custom Synthesis and Radiolabeling Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 HMR Custom Synthesis and Radiolabeling Product Portfolio
- 6.15.5 HMR Recent Developments
- 6.16 AM Chemicals
- 6.16.1 AM Chemicals Company Information
- 6.16.2 AM Chemicals Business Overview
- 6.16.3 AM Chemicals Custom Synthesis and Radiolabeling Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 AM Chemicals Custom Synthesis and Radiolabeling Product Portfolio
- 6.16.5 AM Chemicals Recent Developments
- 6.17 PolyPeptide Group
- 6.17.1 PolyPeptide Group Company Information
- 6.17.2 PolyPeptide Group Business Overview
- 6.17.3 PolyPeptide Group Custom Synthesis and Radiolabeling Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 PolyPeptide Group Custom Synthesis and Radiolabeling Product Portfolio
- 6.17.5 PolyPeptide Group Recent Developments
- 6.18 NovoPro Bioscience
- 6.18.1 NovoPro Bioscience Company Information
- 6.18.2 NovoPro Bioscience Business Overview
- 6.18.3 NovoPro Bioscience Custom Synthesis and Radiolabeling Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 NovoPro Bioscience Custom Synthesis and Radiolabeling Product Portfolio
- 6.18.5 NovoPro Bioscience Recent Developments
- 6.19 Institute of Isotopes
- 6.19.1 Institute of Isotopes Company Information
- 6.19.2 Institute of Isotopes Business Overview
- 6.19.3 Institute of Isotopes Custom Synthesis and Radiolabeling Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 Institute of Isotopes Custom Synthesis and Radiolabeling Product Portfolio
- 6.19.5 Institute of Isotopes Recent Developments
- 6.20 Nuvisan
- 6.20.1 Nuvisan Company Information
- 6.20.2 Nuvisan Business Overview
- 6.20.3 Nuvisan Custom Synthesis and Radiolabeling Revenue, Global Share and Gross Margin (2021-2026)
- 6.20.4 Nuvisan Custom Synthesis and Radiolabeling Product Portfolio
- 6.20.5 Nuvisan Recent Developments
- 6.21 Revvity
- 6.21.1 Revvity Company Information
- 6.21.2 Revvity Business Overview
- 6.21.3 Revvity Custom Synthesis and Radiolabeling Revenue, Global Share and Gross Margin (2021-2026)
- 6.21.4 Revvity Custom Synthesis and Radiolabeling Product Portfolio
- 6.21.5 Revvity Recent Developments
- 6.22 Necsa
- 6.22.1 Necsa Company Information
- 6.22.2 Necsa Business Overview
- 6.22.3 Necsa Custom Synthesis and Radiolabeling Revenue, Global Share and Gross Margin (2021-2026)
- 6.22.4 Necsa Custom Synthesis and Radiolabeling Product Portfolio
- 6.22.5 Necsa Recent Developments
- 6.23 Fluorizon
- 6.23.1 Fluorizon Company Information
- 6.23.2 Fluorizon Business Overview
- 6.23.3 Fluorizon Custom Synthesis and Radiolabeling Revenue, Global Share and Gross Margin (2021-2026)
- 6.23.4 Fluorizon Custom Synthesis and Radiolabeling Product Portfolio
- 6.23.5 Fluorizon Recent Developments
- 6.24 Edinburgh Pharmaceutical Processes
- 6.24.1 Edinburgh Pharmaceutical Processes Company Information
- 6.24.2 Edinburgh Pharmaceutical Processes Business Overview
- 6.24.3 Edinburgh Pharmaceutical Processes Custom Synthesis and Radiolabeling Revenue, Global Share and Gross Margin (2021-2026)
- 6.24.4 Edinburgh Pharmaceutical Processes Custom Synthesis and Radiolabeling Product Portfolio
- 6.24.5 Edinburgh Pharmaceutical Processes Recent Developments
- 6.25 Chelatec
- 6.25.1 Chelatec Company Information
- 6.25.2 Chelatec Business Overview
- 6.25.3 Chelatec Custom Synthesis and Radiolabeling Revenue, Global Share and Gross Margin (2021-2026)
- 6.25.4 Chelatec Custom Synthesis and Radiolabeling Product Portfolio
- 6.25.5 Chelatec Recent Developments
- 6.26 Pharmaron
- 6.26.1 Pharmaron Company Information
- 6.26.2 Pharmaron Business Overview
- 6.26.3 Pharmaron Custom Synthesis and Radiolabeling Revenue, Global Share and Gross Margin (2021-2026)
- 6.26.4 Pharmaron Custom Synthesis and Radiolabeling Product Portfolio
- 6.26.5 Pharmaron Recent Developments
- 6.27 Medicilon
- 6.27.1 Medicilon Company Information
- 6.27.2 Medicilon Business Overview
- 6.27.3 Medicilon Custom Synthesis and Radiolabeling Revenue, Global Share and Gross Margin (2021-2026)
- 6.27.4 Medicilon Custom Synthesis and Radiolabeling Product Portfolio
- 6.27.5 Medicilon Recent Developments
- 6.28 JOINN Laboratories
- 6.28.1 JOINN Laboratories Company Information
- 6.28.2 JOINN Laboratories Business Overview
- 6.28.3 JOINN Laboratories Custom Synthesis and Radiolabeling Revenue, Global Share and Gross Margin (2021-2026)
- 6.28.4 JOINN Laboratories Custom Synthesis and Radiolabeling Product Portfolio
- 6.28.5 JOINN Laboratories Recent Developments
- 6.29 Frontage
- 6.29.1 Frontage Company Information
- 6.29.2 Frontage Business Overview
- 6.29.3 Frontage Custom Synthesis and Radiolabeling Revenue, Global Share and Gross Margin (2021-2026)
- 6.29.4 Frontage Custom Synthesis and Radiolabeling Product Portfolio
- 6.29.5 Frontage Recent Developments
- 6.30 Abace Biotechnology
- 6.30.1 Abace Biotechnology Company Information
- 6.30.2 Abace Biotechnology Business Overview
- 6.30.3 Abace Biotechnology Custom Synthesis and Radiolabeling Revenue, Global Share and Gross Margin (2021-2026)
- 6.30.4 Abace Biotechnology Custom Synthesis and Radiolabeling Product Portfolio
- 6.30.5 Abace Biotechnology Recent Developments
- 6.31 Beijing Atom High-Tech
- 6.31.1 Beijing Atom High-Tech Company Information
- 6.31.2 Beijing Atom High-Tech Business Overview
- 6.31.3 Beijing Atom High-Tech Custom Synthesis and Radiolabeling Revenue, Global Share and Gross Margin (2021-2026)
- 6.31.4 Beijing Atom High-Tech Custom Synthesis and Radiolabeling Product Portfolio
- 6.31.5 Beijing Atom High-Tech Recent Developments
- 6.32 Wuxi Beita Pharmatech
- 6.32.1 Wuxi Beita Pharmatech Company Information
- 6.32.2 Wuxi Beita Pharmatech Business Overview
- 6.32.3 Wuxi Beita Pharmatech Custom Synthesis and Radiolabeling Revenue, Global Share and Gross Margin (2021-2026)
- 6.32.4 Wuxi Beita Pharmatech Custom Synthesis and Radiolabeling Product Portfolio
- 6.32.5 Wuxi Beita Pharmatech Recent Developments
- 6.33 Beijing North Institute of Biotechnology
- 6.33.1 Beijing North Institute of Biotechnology Company Information
- 6.33.2 Beijing North Institute of Biotechnology Business Overview
- 6.33.3 Beijing North Institute of Biotechnology Custom Synthesis and Radiolabeling Revenue, Global Share and Gross Margin (2021-2026)
- 6.33.4 Beijing North Institute of Biotechnology Custom Synthesis and Radiolabeling Product Portfolio
- 6.33.5 Beijing North Institute of Biotechnology Recent Developments
7 North America
- 7.1 North America Custom Synthesis and Radiolabeling Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Custom Synthesis and Radiolabeling Market Size by Country (2021-2026)
- 7.3 North America Custom Synthesis and Radiolabeling Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Custom Synthesis and Radiolabeling Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Custom Synthesis and Radiolabeling Market Size by Country (2021-2026)
- 8.3 Europe Custom Synthesis and Radiolabeling Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Custom Synthesis and Radiolabeling Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Custom Synthesis and Radiolabeling Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Custom Synthesis and Radiolabeling Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Custom Synthesis and Radiolabeling Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Custom Synthesis and Radiolabeling Market Size by Country (2021-2026)
- 10.3 South America Custom Synthesis and Radiolabeling Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Custom Synthesis and Radiolabeling Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Custom Synthesis and Radiolabeling Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Custom Synthesis and Radiolabeling Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst